These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 28921843)
1. Potential proton and photon dose degradation in advanced head and neck cancer patients by intratherapy changes. Stützer K; Jakobi A; Bandurska-Luque A; Barczyk S; Arnsmeyer C; Löck S; Richter C J Appl Clin Med Phys; 2017 Nov; 18(6):104-113. PubMed ID: 28921843 [TBL] [Abstract][Full Text] [Related]
2. Impact of interfractional changes in head and neck cancer patients on the delivered dose in intensity modulated radiotherapy with protons and photons. Müller BS; Duma MN; Kampfer S; Nill S; Oelfke U; Geinitz H; Wilkens JJ Phys Med; 2015 May; 31(3):266-72. PubMed ID: 25724350 [TBL] [Abstract][Full Text] [Related]
3. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer. Rana S; Zheng Y J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310 [TBL] [Abstract][Full Text] [Related]
4. Multi-scenario based robust intensity-modulated proton therapy (IMPT) plans can account for set-up errors more effectively in terms of normal tissue sparing than planning target volume (PTV) based intensity-modulated photon plans in the head and neck region. Stuschke M; Kaiser A; Abu Jawad J; Pöttgen C; Levegrün S; Farr J Radiat Oncol; 2013 Jun; 8():145. PubMed ID: 23773560 [TBL] [Abstract][Full Text] [Related]
6. Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images. Kurz C; Nijhuis R; Reiner M; Ganswindt U; Thieke C; Belka C; Parodi K; Landry G Radiat Oncol; 2016 Apr; 11():64. PubMed ID: 27129305 [TBL] [Abstract][Full Text] [Related]
7. ART for head and neck patients: On the difference between VMAT and IMPT. Góra J; Kuess P; Stock M; Andrzejewski P; Knäusl B; Paskeviciute B; Altorjai G; Georg D Acta Oncol; 2015; 54(8):1166-74. PubMed ID: 25850583 [TBL] [Abstract][Full Text] [Related]
8. Robust Intensity Modulated Proton Therapy (IMPT) Increases Estimated Clinical Benefit in Head and Neck Cancer Patients. van Dijk LV; Steenbakkers RJ; ten Haken B; van der Laan HP; van 't Veld AA; Langendijk JA; Korevaar EW PLoS One; 2016; 11(3):e0152477. PubMed ID: 27030987 [TBL] [Abstract][Full Text] [Related]
9. Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy. Florijn MA; Sharfo AWM; Wiggenraad RGJ; van Santvoort JPC; Petoukhova AL; Hoogeman MS; Mast ME; Dirkx MLP Radiother Oncol; 2020 Jan; 142():147-153. PubMed ID: 31522879 [TBL] [Abstract][Full Text] [Related]
10. Relative plan robustness of step-and-shoot vs rotational intensity-modulated radiotherapy on repeat computed tomographic simulation for weight loss in head and neck cancer. Thomson DJ; Beasley WJ; Garcez K; Lee LW; Sykes AJ; Rowbottom CG; Slevin NJ Med Dosim; 2016; 41(2):154-8. PubMed ID: 26993081 [TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma. Hung HM; Chan OCM; Mak CH; Hung WM; Ng WT; Lee MCH Med Dosim; 2022 Spring; 47(1):14-19. PubMed ID: 34470708 [TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated proton therapy (IMPT) versus intensity-modulated radiation therapy (IMRT) for the treatment of head and neck cancer: A dosimetric comparison. Nguyen ML; Cantrell JN; Ahmad S; Henson C Med Dosim; 2021 Autumn; 46(3):259-263. PubMed ID: 33648823 [TBL] [Abstract][Full Text] [Related]
13. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study. van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA; Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528 [TBL] [Abstract][Full Text] [Related]
14. Dosimetric evaluation of intensity modulated photon versus proton reirradiation of head and neck cancer. Buciuman N; Dasu A; Marcu LG Phys Med; 2024 Jul; 123():103427. PubMed ID: 38959576 [TBL] [Abstract][Full Text] [Related]
15. Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study. Liu G; Li X; Qin A; Zheng W; Yan D; Zhang S; Stevens C; Kabolizadeh P; Ding X Radiat Oncol; 2020 Jan; 15(1):21. PubMed ID: 32000817 [TBL] [Abstract][Full Text] [Related]
16. Comparing cone-beam CT intensity correction methods for dose recalculation in adaptive intensity-modulated photon and proton therapy for head and neck cancer. Kurz C; Dedes G; Resch A; Reiner M; Ganswindt U; Nijhuis R; Thieke C; Belka C; Parodi K; Landry G Acta Oncol; 2015; 54(9):1651-7. PubMed ID: 26198654 [TBL] [Abstract][Full Text] [Related]
17. The partial adaptation strategy for online-adaptive proton therapy: A proof of concept study in head and neck cancer patients. Gambetta V; Fredriksson A; Menkel S; Richter C; Stützer K Med Phys; 2024 Aug; 51(8):5572-5581. PubMed ID: 38837396 [TBL] [Abstract][Full Text] [Related]
18. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison. Kandula S; Zhu X; Garden AS; Gillin M; Rosenthal DI; Ang KK; Mohan R; Amin MV; Garcia JA; Wu R; Sahoo N; Frank SJ Med Dosim; 2013; 38(4):390-4. PubMed ID: 23916884 [TBL] [Abstract][Full Text] [Related]
19. Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking. Munck Af Rosenschöld P; Engelholm S; Ohlhues L; Law I; Vogelius I; Engelholm SA Acta Oncol; 2011 Aug; 50(6):777-83. PubMed ID: 21767174 [TBL] [Abstract][Full Text] [Related]
20. Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial. Eekers DBP; Roelofs E; Jelen U; Kirk M; Granzier M; Ammazzalorso F; Ahn PH; Janssens GORJ; Hoebers FJP; Friedmann T; Solberg T; Walsh S; Troost EGC; Kaanders JHAM; Lambin P Radiother Oncol; 2016 Dec; 121(3):387-394. PubMed ID: 27639891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]